Header search > ticker > Open Stock TerminalSelect the market and trading date first when you need a specific listing or historical session.
TradingFloor AI · Stock TerminalSNY - Ticker AI Digest
Sanofi ADR 📰 1
US500
44.82000000
| Today -0.04%
●
Important AI Risk Notice
Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.
Not investment advice.
Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate.
Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only.
Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally.
Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Sanofi ADR in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, Today’s AI, and the deeper desks.
SNY
Data 2026-08-31
Preview Mode
Core Deck
Deep Dive Modules
Digested News
Today's Catalysts (SNY) 1
AI 3
Acquisitions 0
Admission 0
Agreement 0
Approvals 19
SNY
01:07
Sanofi ADR
SNY
11:10
Sanofi ADR
SNY
09:15
Sanofi ADR
SNY
04:15
Sanofi ADR
SNY
04:15
Sanofi ADR
SNY
04:00
Sanofi ADR
SNY
04:00
Sanofi ADR
SNY
19:43
Sanofi ADR
SNY
09:31
Sanofi ADR
SNY
09:31
Sanofi ADR
SNY
19:06
Sanofi ADR
SNY
13:14
Sanofi ADR
SNY
05:01
Sanofi ADR
SNY
21:09
Sanofi ADR
Authorisation 0
Awards 0
BTC 0
BlockListing 0
Blockchain 0
Breakthrough 0
BuyBack 0
Cancellations 0
CashOffer 0
Circular 0
ClinicalTrial 0
Collaborate 0
ContractWin 0
Covid-19 0
Deals 2
Diamond 0
DirectorDealing 0
DirectorateChange 0
Discovery 0
Dividend 0
Exceeded 0
FCA 0
FDA 2
Form83 0
GeneralMeeting 0
Grants 0
InvestmentPlan 0
IssueOfEquity 0
JV 0
Launch 0
Litigation 0
MonthlyFactsheet 0
NAV 0
NameChange 0
NewContract 0
Offers 0
Offtake 0
Orders 0
OwnShares 0
Partner 1
Patents 1
Placing 0
Positive 0
ProfitWarning 0
Proposals 0
Prospectus 0
Reports 2
Results 3
SchemeOfArrangement 0
Significant 0
Speculation 0
Strategic 0
Suspension 0
TR1 0
TVR 0
Takeover 0
US News 0
Understanding 0
Updates 4
Vaccine 4
Wins 2
Worth 0
All Market News (Last 30 Days) 119
SNY
10:00
Sanofi ADR
SNY
21:52
Sanofi ADR
SNY
12:41
Sanofi ADR
SNY
15:00
Sanofi ADR
SNY
14:34
Sanofi ADR
SNY
14:34
Sanofi ADR
SNY
07:40
Sanofi ADR
SNY
07:30
Sanofi ADR
SNY
14:12
Sanofi ADR
SNY
12:19
Sanofi ADR
SNY
01:07
Sanofi ADR
SNY
15:07
Sanofi ADR
SNY
14:11
Sanofi ADR
SNY
13:31
Sanofi ADR
SNY
11:05
Sanofi ADR
SNY
11:05
Sanofi ADR
SNY
04:00
Sanofi ADR
SNY
04:00
Sanofi ADR
SNY
04:00
Sanofi ADR
SNY
12:00
Sanofi ADR
SNY
05:00
Sanofi ADR
SNY
05:00
Sanofi ADR
SNY
05:00
Sanofi ADR
SNY
13:31
Sanofi ADR
SNY
11:10
Sanofi ADR
SNY
09:15
Sanofi ADR
SNY
08:07
Sanofi ADR
SNY
04:15
Sanofi ADR
SNY
04:15
Sanofi ADR
SNY
04:15
Sanofi ADR
SNY
04:00
Sanofi ADR
SNY
04:00
Sanofi ADR
SNY
04:00
Sanofi ADR
SNY
19:43
Sanofi ADR
SNY
14:06
Sanofi ADR
SNY
11:30
Sanofi ADR
SNY
02:16
Sanofi ADR
SNY
09:31
Sanofi ADR
SNY
09:31
Sanofi ADR
SNY
09:31
Sanofi ADR
SNY
07:00
Sanofi ADR
SNY
13:01
Sanofi ADR
SNY
14:10
Sanofi ADR
SNY
21:30
Sanofi ADR
SNY
18:58
Sanofi ADR
SNY
16:00
Sanofi ADR
SNY
15:05
Sanofi ADR
SNY
14:09
Sanofi ADR
SNY
13:54
Sanofi ADR
SNY
19:06
Sanofi ADR
SNY
13:14
Sanofi ADR
SNY
05:01
Sanofi ADR
SNY
21:09
Sanofi ADR
SNY
21:09
Sanofi ADR
SNY
21:09
Sanofi ADR
SNY
11:22
Sanofi ADR
SNY
14:07
Sanofi ADR
SNY
13:15
Sanofi ADR
SNY
12:05
Sanofi ADR
SNY
04:00
Sanofi ADR
SNY
04:00
Sanofi ADR
SNY
04:00
Sanofi ADR
SNY
10:00
Sanofi ADR
SNY
10:00
Sanofi ADR
SNY
14:47
Sanofi ADR
SNY
14:10
Sanofi ADR
SNY
04:52
Sanofi ADR
Today's AI
SNY · Agentic Market Intelligence
SNY intelligence is listening.
The engine is monitoring news, price structure, forecasts and financial changes. New scored evidence will appear here against this stock automatically.
AI bias0.0
Bullish0
Bearish0
Today's AI Starts With News
1 live catalyst is opening Today’s AI for SNY.
Start with the live headline tape first. Today’s AI findings sit next, and the AI Blend stack drops lower once the news context is framed. Financial Forecastist now feeds the blend too.
Live Tape
Data 2026-08-31
Blend Lower Down
Read the alert tape first, then open Today’s AI findings. Use AI Expand on any card to open the AI explanation, results tables and financial forecast rows instantly.
1
Today
Front Of Desk
Sanofi ADR has fresh news flow live now, so Today’s AI is leading with the tape before the blended signal stack below.
Single-Ticker Today's AI
SNY signal theatre built from scored market catalysts, automated AI forecasts, financial forecasting and live trigger logic.
This is the ticker-specific Today’s AI desk for Sanofi ADR. It compresses the live catalyst tape, bullish and bearish scoring, AI price forecasts, financial forecasting and trigger logic into one cockpit so users can judge conviction without hopping across screens.
Subscription Required
Bullish vs Bearish Scoring
AI + Financial Blend
Buy / Sell Trigger Engine
Today's AI Findings
Subscriber Unlock
Subscribe to unlock the full SNY Today’s AI cockpit.
Subscription turns this tab into a live signal desk with today’s news findings at the top, AI plus financial blend comparisons at the bottom, buy and sell trigger logic, and the full findings ledger behind every scored row.
- AI-scored market headlines with sentiment buckets and buzzword breakdowns.
- Forecast leaders ranked by projected gain against current market price.
- Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
- Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
- Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
- Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific Today’s AI stack, sentiment gauges, AI blend stage, and the full findings ledger for SNY on 2026-08-31.
Fundamentals Matrix
About Sanofi ADR
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
105.1B
Enterprise Value
119.2B
Public Float
90.9
Broker Target
55.0556
Shares Out
2.4B
Long Interest
100
Short Interest
0
Exchange
NASDAQ
Currency Code
USD
ISIN
US80105N1054
Ex-Dividend
2026-05-04
Yield
5.65%
Dividend Rate
2.42
EPS
2.31
Market
NASDAQ
Standard Lists
US500
Sector
Pharmaceuticals and BiotechnologyUS fundamentals
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-
Financials Matrix
News And Alerts First
1 live alert now opens the financials desk for SNY.
Start with the headline flow and alert tape first. Then drop straight into Financial Forecastist below for the revenue path, EPS shape, cash pressure and balance-sheet read while the catalyst context is still hot.
Live Alerts
Data 2026-08-31
Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
1
Alerts
Front Of Desk
Sanofi ADR has fresh filing flow live now, so the tape is framing the revenue, leverage and valuation story below.
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
2.42
Ex Divi
2026-05-04
Earnings Date
-
Net Debt
12.7B
Cash
7.7B
EPS
2.31
Net Income
7.8B
Revenue
47.4B
Enterprise Value
119.2B
Trailing PE
19.0043
Forward PE
8.6881
Price Sales TTM
2.2192
Price Book MRQ
1.2351
EV Revenue
2.2107
EV EBITDA
12.2828
Financial Forecastist
Worsening financial engine
Revenue is accelerating +6.0% against the prior comparable period. Net margin is compressing by 3.3 pts. Net debt is building +10.9%.
Revenue +6.0%
Net Income -13.8%
FCF -19.6%
Current Ratio 1.01x
Forward Rev 13.5B
Worsening
Quarter Revenue
11.2B
+6.0%
vs prior comparable quarter
Net Margin
+14.4%
-3.3 pts
profitability pulse
Free Cash Flow
1.7B
-19.6%
cash conversion
Net Debt / EBITDA
5.3x
+10.9%
lower is cleaner
Revenue Engine
Latest quarter printed 11.2B with the top line pushing higher against the last comparable period.
Profit Stack
Net income landed at 1.6B and the margin profile is tightening. That usually tells us whether operating leverage is finally kicking in.
Balance-Sheet Pressure
Cash sits near 5.5B while net debt is 14.5B. The leverage stack is moving the wrong way.
Quarterly Revenue Runway
Actual revenue bars, consensus revenue where available, plus the terminal model path.
Profit And Cash Conversion
Net income and free cash flow moving together is usually what separates genuine improvement from noise.
Balance-Sheet Pressure
Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.
Annual Power Curve
Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q3 2025
Consensus
12.4B
Revenue Path
1.58
EPS / Earnings
Growth cue +0.0%
Q1 2026
Consensus
10.2B
Revenue Path
1.03
EPS / Earnings
Growth cue +0.0%
Q2 2026
Consensus
11.0B
Revenue Path
1.14
EPS / Earnings
Growth cue +0.3%
Q3 2026
Consensus
13.5B
Revenue Path
1.60
EPS / Earnings
Growth cue -0.1%
FY 2026
Consensus
47.2B
Revenue Path
4.79
EPS / Earnings
Growth cue +0.0%
FY 2027
Consensus
50.3B
Revenue Path
5.14
EPS / Earnings
Growth cue +0.1%
Quarterly Statement Tape
Last 6 Quarters
| Period | Revenue | Net Income | FCF | Net Debt |
|---|---|---|---|---|
| Q1 2026 | 11.2B | 1.6B | 1.7B | 14.5B |
| Q4 2025 | 12.2B | -801.0M | 1.6B | 12.7B |
| Q3 2025 | 13.2B | 2.8B | 4.6B | 12.8B |
| Q2 2025 | 10.7B | 3.9B | 42.0M | 6.9B |
| Q1 2025 | 10.6B | 1.9B | 2.1B | 13.1B |
| Q4 2024 | 7.6B | 499.0M | - | 10.5B |
Annual Financial Power
Last 5 Years
| Period | Revenue | Net Income | EBITDA | FCF |
|---|---|---|---|---|
| FY 2025 | 46.7B | 7.8B | 12.5B | 10.1B |
| FY 2024 | 44.3B | 5.6B | 11.0B | 5.9B |
| FY 2023 | 41.6B | 5.4B | 11.4B | 8.6B |
| FY 2022 | 40.6B | 8.4B | 13.5B | 8.3B |
| FY 2021 | 39.2B | 6.2B | 11.5B | 8.5B |
Structure DNA
Market Structure DNA
Income Anchor profile with trend mixed
Price is 33.4% through the 52-week range, +0.9% vs 50DMA and -6.3% vs 200DMA. 8.9% of the register is locked by institutions and insiders, leaving 91.1% free float. Capital rhythm reads annual with forward yield near 5.7% and payout around 56.9%.
Trend mixed
Balanced register
Reliable income rhythm
As Of 2026-07-10
Income Anchor
Structure Score
55.5 / 100
Income Anchor
Trend Stack
+0.9% / -6.3%
vs 50DMA / 200DMA
52W Position
33.4%
auction position inside the yearly range
Ownership Lock
8.9%
8.9% institutions | 0.1% insiders
Pressure Pocket
0.3% short float
Short ratio 2.6x | monthly -4.5%
Capital Rhythm
Annual
Yield 5.7% | payout 56.9%
Trend Runway
Implied spot is 43.90 with the stock +0.9% vs 50DMA and -6.3% vs 200DMA. The tape is sitting 33.4% through the 52-week range, which frames the regime as trend mixed.
Ownership Register
Institutions hold about 8.9% and insiders about 0.1%, locking roughly 8.9% of the register and leaving 91.1% in free float. That reads as balanced register.
Pressure Pocket
Short pressure is running near 0.3% of float with short ratio 2.6x and monthly change -4.5%. That gives us a read on whether the tape is clean, crowded, or coiled.
Capital Rhythm
Dividend cadence reads annual with 1 event(s) in the last full year, a five-year average of 1.2, and stability score 80.0/100. Forward yield sits near 5.7% while payout is around 56.9%.
Structure Score
One-glance gauge for the current market-structure regime.
Pillar Radar
Trend, ownership, pressure, and capital rhythm mapped on one wheel.
Position And Float Balance
Shows whether the stock is extended, tightly held, or carrying capital-return support.
Dividend Cadence Tape
Historical dividend-event counts help reveal how dependable the income rhythm has been.
Dividend Cadence Ledger
Annual
| Year | Dividend Count | Context |
|---|---|---|
| 2026 | 1 | Current partial year |
| 2025 | 1 | Full year |
| 2024 | 1 | Full year |
| 2023 | 1 | Full year |
| 2022 | 2 | Full year |
| 2021 | 1 | Full year |
| 2020 | 1 | Full year |
| 2019 | 1 | Full year |
Structure Facts
Live Snapshot
Implied Spot
43.90
derived from market cap / shares
52W High
49.91
upper auction edge
52W Low
40.89
lower auction edge
Beta
0.28
volatility character
Shares Out
2.4B
fully diluted count
Shares Float
2.2B
tradable register
Shares Short
6.4M
borrowed stock
Short Ratio
2.6x
days-to-cover style read
Ex-Dividend
2026-05-04
-67 day(s) to ex-date
Dividend Pay
2026-06-03
-37 day(s) to pay date
Last Split
5:1
2013-09-30
Capital Radar
Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
7.5986
Institutions As Of
2026-05-31
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
0
Sale Director Dealing
0
Purchase TR1
0
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
40
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder
Short Data · SNY · Last 30 Days
Short D · 12/26 EMA spread with 9 signal
Red histogram bars show short loading accelerating. Green bars show short covering accelerating. The two lines expose the crossover before the raw holder table does.
Short D waiting
Building SNY short-momentum read
Short D compares the ticker’s disclosed short-position momentum with its own signal line.
Short D—
Signal—
Momentum—
Declared Short Holders
Nexus Pulse Engine
Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending
Volatility Lab
ATR(14)
Realized Vol (20d)
Volume Spike Z
AI Charts
News And Alerts First
The alert tape opens the door for SNY, and AI Charts sits just below.
Start with the headline flow and live catalyst tape first. Then move straight into AI Charts below for price reaction, AI targets, chart structure and catalyst beacons while the news context is still hot.
Live Tape
Data 2026-08-31
AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
1
Today
Catalyst Pulse
Sanofi ADR has fresh news flow live now, so the tape is framing the chart workspace below.
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.
Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.
Automated Signalling
Automated AI Forecasts
Predictive MACD
Catalyst Beacons
Live Price Structure
AI AutoDetection
Automatic bull / bear chart read
Detected market structure
Analysing selected range
Why this call
Waiting for sufficient price history.
Invalidation
—
Updates with the timeframe.
Bull caseCalculating upside confirmation.
Bear caseCalculating downside confirmation.
AI Forecast 27.18%
RSI Gauge
Price Change
AI Forecast